MoonLake Investors Urged to Seek Lead Role in Securities Case as Dec. 15 Deadline Nears
Multiple law firms are recruiting shareholders after SLK’s Phase 3 results triggered a collapse in MLTX shares.
Overview
- Glancy Prongay & Murray and The Gross Law Firm reminded MLTX holders of the December 15, 2025 deadline to move for lead-plaintiff appointment.
- Rosen Law Firm told purchasers they may secure counsel on a contingency basis and noted that no class has been certified.
- Faruqi & Faruqi said a federal securities action has been filed and invited tips from whistleblowers, former employees, and shareholders.
- Complaints claim MoonLake misled investors about SLK’s touted nanobody benefits and its shared IL-17A/IL-17F targets with rival BIMZELX.
- The actions follow MoonLake’s September 28 disclosure that SLK failed to show competitive efficacy at week 16 versus BIMZELX, which preceded an 89.9% one-day drop to $6.24.